Blog
RSS FeedPosted by Michael Wonder on 29 Oct 2020
Sales of cancer fighting drugs soared in Canada over the past decade
29 October 2020 - Canada is the only country with a universal health care system without coverage for prescription drugs. ...
Posted by Michael Wonder on 28 Oct 2020
COVID-19 vaccine attitudes differ in Australia as experts say we're at a 'precarious time'
29 October 2020 - Andrea Vincita hasn't seen her family in a year. ...
Posted by Michael Wonder on 27 Oct 2020
Sales of cancer medicines in Canada nearly tripled over the past decade
27 October 2020 - Today, the PMPRB, under the National Prescription Drug Utilization Information System (NPDUIS) initiative, released a chartbook ...
Posted by Michael Wonder on 29 Sep 2020
Germany has not fully realised its biosimilar potential
29 September 2020 - Investigators have concluded that fully realizing the cost-saving potential of biosimilars could “release enormous resources” for ...
Posted by Michael Wonder on 14 Sep 2020
U.S. hospitals turn down remdesivir, limit use to sickest COVID-19 patients
12 September 2020 - U.S. hospitals have turned down about a third of their allocated supplies of the COVID-19 drug remdesivir ...
Posted by Michael Wonder on 20 Aug 2020
Three-quarters of New Zealanders intend to get COVID-19 vaccine
20 August 2020 - Three-quarters of New Zealanders say they would get the Covid-19 vaccine once it becomes available, new ...
Posted by Michael Wonder on 17 Aug 2020
Irish pharmacists lobby for biosimilar substitution
17 August 2020 - Pharmacists in Ireland say the country is losing out on hundreds of millions of dollars in savings ...
Posted by Michael Wonder on 13 Aug 2020
Disney official, others, talk about switch to biosimilars
12 August 2020 - Dismayed at the low biosimilar uptake and the lost savings, large employers are taking matters into their ...
Posted by Michael Wonder on 13 Aug 2020
Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19
13 August 2020 - While the focus of attention currently is on developing a vaccine against the Coronavirus SARS-CoV-2 to protect ...
Posted by Michael Wonder on 03 Aug 2020
Slow start for infliximab biosimilars
3 August 2020 - Investigators speculate on why infliximab biosimilars don’t have a larger market share by now. ...
Posted by Michael Wonder on 27 Jul 2020
Biosimilar insulin glargine on the PBS - information for health professionals and patients
27 July 2020 - Changes have been made from 1 July 2020 to the PBS listings for insulin glargine, as the ...
Posted by Michael Wonder on 14 Jul 2020
Biosimilar Awareness Week proves successful for Australia
13 July 2020 - The Generic and Biosimilar Medicines Association in Australia reported its 2020 Biosimilar Awareness Week was successful, with ...
Posted by Michael Wonder on 07 Jul 2020
Remove the disincentives and biosimilars will flourish, policy expert says
7 July 2020 - Patients could save as much as 17% on out-of-pocket costs if they used biosimilars, but many ...
Posted by Michael Wonder on 07 Jul 2020
Use of infliximab biosimilar in Medicare population is low but growing
7 July 2020 - Slow growth of use of biosimilar infliximab in a Medicare fee-for-service population suggests lingering hesitancy on the ...
Posted by Michael Wonder on 29 Jun 2020
Demand for dexamethasone soars after promising findings in UK
27June 2020 - Weekly demand in the U.S. is up more than 600%. ...